JP7765681B2 - エクソソーム模倣物のラージスケール生成およびそれらの使用 - Google Patents

エクソソーム模倣物のラージスケール生成およびそれらの使用

Info

Publication number
JP7765681B2
JP7765681B2 JP2022510109A JP2022510109A JP7765681B2 JP 7765681 B2 JP7765681 B2 JP 7765681B2 JP 2022510109 A JP2022510109 A JP 2022510109A JP 2022510109 A JP2022510109 A JP 2022510109A JP 7765681 B2 JP7765681 B2 JP 7765681B2
Authority
JP
Japan
Prior art keywords
exosome
disease
cells
cancer
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022510109A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545656A5 (cg-RX-API-DMAC7.html
JP2022545656A (ja
Inventor
モーゼス,マーシャ,エー.
グオ,ペン
ムーラッド,ゴルナズ
ファン,ジン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Children's Hospital
Original Assignee
Boston Children's Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Children's Hospital filed Critical Boston Children's Hospital
Publication of JP2022545656A publication Critical patent/JP2022545656A/ja
Publication of JP2022545656A5 publication Critical patent/JP2022545656A5/ja
Application granted granted Critical
Publication of JP7765681B2 publication Critical patent/JP7765681B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1896—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
    • A61B5/4064—Evaluating the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/0035—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/004—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
    • A61B5/0042—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Botany (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
JP2022510109A 2019-08-16 2020-08-13 エクソソーム模倣物のラージスケール生成およびそれらの使用 Active JP7765681B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962887876P 2019-08-16 2019-08-16
US62/887,876 2019-08-16
PCT/US2020/046050 WO2021034582A1 (en) 2019-08-16 2020-08-13 Large scale production of exosome mimetics and uses thereof

Publications (3)

Publication Number Publication Date
JP2022545656A JP2022545656A (ja) 2022-10-28
JP2022545656A5 JP2022545656A5 (cg-RX-API-DMAC7.html) 2023-08-22
JP7765681B2 true JP7765681B2 (ja) 2025-11-07

Family

ID=74659601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022510109A Active JP7765681B2 (ja) 2019-08-16 2020-08-13 エクソソーム模倣物のラージスケール生成およびそれらの使用

Country Status (6)

Country Link
US (1) US20220288241A1 (cg-RX-API-DMAC7.html)
EP (1) EP4013391A4 (cg-RX-API-DMAC7.html)
JP (1) JP7765681B2 (cg-RX-API-DMAC7.html)
CN (1) CN114980869B (cg-RX-API-DMAC7.html)
CA (1) CA3150734A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021034582A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12241888B2 (en) 2018-03-14 2025-03-04 Children's Medical Center Corporation Platform for assessment of the transcytosis of extracellular vesicles across endothelial barriers and uses thereof
CN115137723B (zh) * 2022-09-06 2023-05-05 深圳市茵冠生物科技有限公司 醋酸钙梯度主动载药法制备维a酸外泌体模拟物
CN116200392B (zh) * 2023-02-24 2026-08-11 杭州佰辰医学检验所有限公司 特异性结合丙戊酸钠小分子的核酸适配体、试剂盒及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012532124A (ja) 2009-07-01 2012-12-13 イオン メディックス インコーポレイテッド 哺乳類の有核細胞に由来するマイクロベシクル及びその用途
CN108175759A (zh) 2016-12-08 2018-06-19 暨南大学 一种抗肿瘤靶向给药系统及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA037503B1 (ru) * 2014-01-21 2021-04-05 Анджариум Байосайенсиз Аг Способ получения гибридосомы, гибридосома, полученная при помощи способа, и способ доставки терапевтического или диагностического средства
KR101720851B1 (ko) * 2015-01-29 2017-03-28 포항공과대학교 산학협력단 세포의 지질막에서 유래된 나노소포체 및 이의 용도
WO2019151744A1 (ko) * 2018-01-31 2019-08-08 서울대학교산학협력단 성체줄기세포 유래의 나노베시클 및 이의 표적 치료용 용도

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012532124A (ja) 2009-07-01 2012-12-13 イオン メディックス インコーポレイテッド 哺乳類の有核細胞に由来するマイクロベシクル及びその用途
CN108175759A (zh) 2016-12-08 2018-06-19 暨南大学 一种抗肿瘤靶向给药系统及其制备方法与应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KIM, H. Y. et al.,Therapeutic efficacy-potentiated and diseased organ-targeting nanovesicles derived from mesenchymal stem cells for spinal cord injury treatment,Nano Letters,2018年07月11日,Vol. 18, No. 8,P. 4965-4975

Also Published As

Publication number Publication date
CN114980869B (zh) 2024-08-27
EP4013391A4 (en) 2023-08-09
CN114980869A (zh) 2022-08-30
EP4013391A1 (en) 2022-06-22
JP2022545656A (ja) 2022-10-28
US20220288241A1 (en) 2022-09-15
CA3150734A1 (en) 2021-02-25
WO2021034582A1 (en) 2021-02-25

Similar Documents

Publication Publication Date Title
Yan et al. Engineering cell membrane‐based nanotherapeutics to target inflammation
Pulford et al. Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrPC on neuronal cells and PrPRES in infected cell cultures
Srivastava et al. Exploitation of exosomes as nanocarriers for gene-, chemo-, and immune-therapy of cancer
Wang et al. Exosomes: a novel strategy for treatment and prevention of diseases
US20180311377A1 (en) Drug delivery systems using fc fragments
CN114980869B (zh) 外排体模拟物的大规模产生及其用途
CN107427466B (zh) 从细胞膜衍生的纳米囊泡及其用途
US12296016B2 (en) Ceramide-like lipid-based delivery vehicles and uses thereof
WO2011158933A1 (ja) 腎線維症処置剤
US20250242046A1 (en) Allogeneic hypoimmune biomimetic nanovesicle for the treatment of cancer
US12383606B2 (en) Short chain ceramide-based lipids and uses thereof
JP2024525795A (ja) Cldn6陽性癌を治療するための、cldn6およびcd3結合要素をコードする薬剤
JP2025518125A (ja) 生体模倣型ナノ小胞を作製するための低免疫原性細胞
US20220275371A1 (en) Use of rab7 gtpase (rab7) inhibitors in enhancing permeability of the blood brain barrier (bbb)
US12551451B2 (en) Compositions and methods for delivering molecules
Jain et al. A novel method for producing functionalized vesicles that efficiently deliver oligonucleotides in vitro and in vivo in mice
JP2025538384A (ja) 血球貪食性リンパ組織球症(hlh)関連疾患のための低免疫原性生体模倣ナノ小胞送達システム
Nassar et al. Extracellular vesicles: fundamentals and clinical relevance

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230814

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230814

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240917

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241101

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250328

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250702

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20250801

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20250801

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250801

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251006

R150 Certificate of patent or registration of utility model

Ref document number: 7765681

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150